Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference0.6%
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.3.SummaryDifference0.0%
- Check41 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.8%
- Check69 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check84 days agoChange DetectedThe web page has undergone significant changes in its content regarding a clinical study for breast cancer treatment, including the addition of new collaborators and a revision update, while extensive details about the study's purpose and criteria have been removed.SummaryDifference15%
Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.